The global personalized medicine market was valued at USD 567.1 billion in 2024. It is projected to reach USD 656.5 billion in 2026 and USD 1,196.2 billion by 2033, expanding at a CAGR of 8.8% from 2025 to 2033.

North America represented the largest regional market in 2024, accounting for 40.2% of global revenue. Asia Pacific is expected to register the fastest growth over the forecast period.

The increasing need for targeted therapies and precision diagnostics remains a major factor supporting market expansion.

What Is Driving the Personalized Medicine Market?

The growing prevalence of chronic and complex diseases is encouraging healthcare providers to adopt individualized treatment strategies. Conditions including cancer, diabetes, and cardiovascular diseases often require treatment decisions based on patient-specific characteristics, increasing demand for approaches that can improve therapeutic outcomes while limiting adverse effects.

Personalized medicine also supports more efficient healthcare resource utilization by helping providers select therapies and diagnostic approaches according to individual patient profiles.

Genomics and Biomarker Discovery

Advances in genomic technologies are expanding the ability of healthcare professionals to identify disease-related genetic characteristics and biomarkers. Next-generation sequencing, bioinformatics, and molecular analysis are helping companies develop diagnostic and therapeutic solutions tailored to specific patient populations.

Personalized diagnostics can improve disease identification and support earlier intervention. For example, in 2024, Illumina's FDA-approved TruSight Oncology Comprehensive test analyzed more than 500 genes to help guide targeted cancer treatments.

Growing consumer awareness of genetic predispositions is also supporting adoption of DNA-based testing services and other personalized diagnostic solutions.

Artificial Intelligence and Data Analytics

AI and advanced data analytics are becoming increasingly relevant to personalized healthcare. Healthcare companies are using AI to process complex clinical and genomic datasets, supporting more efficient analysis and assisting treatment-selection processes.

Telemedicine platforms and health IT systems are also expanding access to individualized healthcare services. These technologies can support remote care and chronic disease management while enabling healthcare providers to incorporate patient-specific information into treatment strategies.

Investment and Strategic Collaboration

Private-sector investment and partnerships are contributing to innovation across the personalized medicine ecosystem. Pharmaceutical companies are collaborating with diagnostics providers to develop companion diagnostics associated with targeted therapies.

Startups and biotechnology companies are introducing solutions in areas such as genomics, nutrition, and wellness. At the consumer level, growing interest in preventive healthcare and health optimization is supporting demand for direct-to-consumer genetic testing and customized wellness programs.

Download a free sample report or claim your copy of this full market intelligence report

Key Market Trends & Insights

• The U.S. personalized medicine industry is expected to experience significant growth during the forecast period.
• Personalized nutrition & wellness represented the largest product segment in 2024, with a 32.0% revenue share.
• Hospitals accounted for the largest share by end use in 2024.
• North America held the leading regional position in 2024.
• Asia Pacific is projected to be the fastest-growing regional market.
• Genomics, biomarker discovery, AI, and data analytics are strengthening the development of individualized healthcare solutions.
• Targeted therapies and precision diagnostics remain important sources of market demand.

Personalized Medicine Market Size & Forecast

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Market Structure and Competitive Characteristics

The personalized medicine market is characterized by substantial innovation as genomics, bioinformatics, molecular diagnostics, and AI-driven healthcare technologies continue to advance. Companies are expanding their capabilities in sequencing, predictive analytics, and personalized diagnostics to address demand across oncology, rare diseases, and other medical applications.

Strategic collaboration is another notable characteristic of the industry. Partnerships between technology companies, healthcare organizations, pharmaceutical manufacturers, and diagnostics providers are helping integrate data, diagnostic testing, and treatment development.

At the same time, the industry presents considerable barriers to entry. Developing genomic testing laboratories, advanced diagnostics infrastructure, or telemedicine systems requires specialized technology, skilled personnel, and significant capital investment. Regulatory approvals, data integration requirements, and intellectual property considerations can further increase the complexity of entering the industry.

Established companies benefit from existing infrastructure, technical expertise, economies of scale, and market relationships. These factors can make it more difficult for smaller companies to compete directly, particularly in highly specialized segments.

Leading Personalized Medicine Companies

Key companies identified in the personalized medicine market include:

• GE Healthcare
• Illumina, Inc.
• ASURAGEN, INC.
• Abbott
• Dako A/S
• Exact Sciences Corporation
• Danaher Corporation (Cepheid, Inc.)
• Decode Genetics, Inc.
• QIAGEN
• Exagen Inc.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.